Cancer-Selective Targeting of the NF-?B Survival Pathway with GADD45ß/MKK7 Inhibitors (2014)
Attributed to:
Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ccr.2014.07.027
PubMed Identifier: 25314077
Publication URI: http://europepmc.org/abstract/MED/25314077
Type: Journal Article/Review
Parent Publication: Cancer Cell
Issue: 4
ISSN: 1535-6108